"Oplis" mycoplasma azithromycin resistance multi-standard nucleic acid test reagent set - Taiwan Registration fabe7b06eb8b0bed119f194134be2f02
Access comprehensive regulatory information for "Oplis" mycoplasma azithromycin resistance multi-standard nucleic acid test reagent set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fabe7b06eb8b0bed119f194134be2f02 and manufactured by SEEGENE INC.. The authorized representative in Taiwan is MEDICARE PRODUCTS INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
fabe7b06eb8b0bed119f194134be2f02
DHA05603520705
Product Details
This product is Real-Time PCR, which is used to detect mutations in A2058G, A2058C, A2058T, A2059G, A2059C and A2059T of Mycoplasma genitalis located in the 23S rRNA gene that is resistant to azithromycin.
C Immunology and microbiology
C.1640 ๆ่ๆๅๆง่ฉฆ้ฉ็ฒๆซ
Input;; QMS/QSD
Dates and Status
Jan 19, 2022
Jan 19, 2027